What the labels show at a glance
A quick summary of the three changes this page covers. A change that is not on the label can still matter to you and your prescriber, and a dated log makes it easier to talk about.
| Change | Listed on the labels? | What to do |
|---|---|---|
| Fatigue | Yes: rates on the Wegovy®, Zepbound® and Foundayo™ labels, more often than with placebo; also listed on Ozempic® and Mounjaro® | Log energy daily; call if it comes with dizziness or keeps getting worse |
| Hot flashes and flushing | Not listed as a side effect on any of the six labels | Log each episode; mention it at your next visit |
| Period changes | Not listed as a side effect on any of the six labels | Log dates and details; take a pregnancy test if a period is late |
Why does timing matter?
Seeing whether a change follows shot days, dose increases or your cycle can help separate causes. That takes a few weeks of simple notes.
What is the boxed warning on these labels?
Every label on this page opens with a boxed warning, the FDA's most prominent kind, about the risk of thyroid C-cell tumors. GLP-1 medicines caused these tumors in rats and mice, and it is not known whether they cause them in people, including a thyroid cancer called medullary thyroid carcinoma (MTC). The Foundayo™ label notes that orforglipron is not active in rodents and did not cause tumors in them, and it carries the same boxed warning.
All six labels say not to use the medicine if you or a family member has had MTC, or if you have a condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). The Medication Guides tell patients to contact their healthcare provider about a lump or swelling in the neck, hoarseness, trouble swallowing or shortness of breath.
Fatigue: what the trial numbers show
Fatigue is the one change in this guide that the labels quantify. These figures come from each label's adverse-reaction table for its weight-reduction trials, with placebo for comparison. Each label counts related terms together, noted in the last column.
| Medicine | Fatigue on the medicine | Fatigue on placebo | What the label counts |
|---|---|---|---|
| Wegovy® injection | 11% | 5% | Fatigue and weakness (asthenia) |
| Zepbound® | 5% to 7% across the doses studied | 3% | Fatigue, weakness, lethargy and malaise |
| Foundayo™ | 6% to 9% across the doses studied | 4% | Fatigue and related terms |
Eating less and losing fluids
Smaller meals can mean less fuel through the day, and the labels warn that vomiting or diarrhea can lead to dehydration. Logging food and water alongside your energy can help show whether low days follow light eating.
When does tiredness need a call?
Tiredness with dizziness, fainting or signs of dehydration is worth a call to your prescriber. So is fatigue that keeps getting worse instead of easing.
Hot flashes, flushing and sweating
Hot flashes are the change people search for most. The plain answer is that they are not on the labels, which is a reason to note them and ask, not to ignore them.
Not on the side effect lists
Hot flashes and flushing do not appear among the side effects on the Ozempic®, Wegovy®, Mounjaro®, Zepbound®, Rybelsus® or Foundayo™ labels. If they start or change after you begin a GLP-1, note it and mention it at your next visit.
Other things your prescriber may ask about
Midlife hormone changes, other medicines, illness and sleep can all play a part. If you are in your 40s or 50s, the GLP-1 perimenopause guide covers what to log during that stage.
Sweating and low blood sugar
The Wegovy® Medication Guide lists sweating among the signs of low blood sugar, a risk for people with type 2 diabetes, especially those who also take insulin or a sulfonylurea. The signs it lists include:
- Dizziness or light-headedness, sweating, shakiness
- Blurred vision, slurred speech, weakness
- Anxiety, hunger, headache, irritability or mood changes
- Confusion or drowsiness, a fast heartbeat, feeling jittery
Log each episode
Note the date, how strong it felt and what else was going on, such as a meal, a dose or a bad night. If sweating comes with shakiness, confusion or a fast heartbeat, follow the low blood sugar plan your prescriber gave you and contact them.
Menstrual cycle shifts: facts and notes to keep
Period changes raise both health and pregnancy questions, so the label facts and the pregnancy notes belong together.
Not listed on the labels
Menstrual changes are not listed as side effects on these GLP-1 labels. Weight change, stress and life stage can all affect a cycle, so a record helps your prescriber look at the whole picture.
The birth control note for tirzepatide (Mounjaro®, Zepbound®)
The Mounjaro® and Zepbound® labels say tirzepatide may reduce how well birth control pills work, because it slows stomach emptying, and that this delay is largest after the first dose and lessens over time. They advise people using oral hormonal birth control to switch to a non-oral method, or add a barrier method, for 4 weeks after starting and for 4 weeks after each dose increase. Hormonal birth control that is not taken by mouth should not be affected, the labels say.
The birth control note for Foundayo™
The Foundayo™ label asks women who could become pregnant to use effective birth control during treatment. Because slower stomach emptying may affect how pills are absorbed, it advises people using oral hormonal birth control to switch to a non-oral method, or add a barrier method, for 30 days after starting and for 30 days after each dose increase.
A missed period can mean pregnancy
If a period is late, take a pregnancy test and call your prescriber.
The Wegovy®, Zepbound® and Foundayo™ labels say weight loss offers no benefit during pregnancy and may cause harm to the baby. Zepbound® and Foundayo™ say to stop once a pregnancy is recognized, and Wegovy® says to stop it in pregnant patients using it for weight reduction or heart-risk reduction. The Mounjaro®, Ozempic®, and Rybelsus® and Ozempic® tablets labels, written for type 2 diabetes, say the medicine should be used in pregnancy only if the potential benefit justifies the potential risk to the baby. Whichever you take, contact your prescriber right away.
What to write down
Keep these together, with your shot days in the same app, so the timing is easy to compare:
- Start date and how long it lasted
- Flow, and any pain
- Anything unusual, such as spotting between periods
From the makers of this guide
A simple setup for logging these changes in Pep AI
Map the three changes to what Pep AI records, and the advice becomes a routine.
- 01
Add your own symptoms
Choose from a built-in list, including fatigue and mood changes, or add your own, such as hot flashes or a period change. Each is rated and dated, and you can add a note for the day.
- 02
Check in on energy, mood and sleep
A short daily check-in records your energy and mood and asks how you slept. Sleep hours can sync from Apple Health or Health Connect.
- 03
Line changes up with your doses
Your dose history and symptom log are both dated, so you can see whether fatigue follows shot day, or whether hot flashes line up with period changes you log as your own symptom.
- 04
Give it a few weeks
One bad day says little. Several weeks of entries, including good days, can help show a pattern and keep the comparison fair.
When to call your prescriber instead of just tracking
Tracking should never delay care. This list draws on the labels' warning signs plus a few general prompts, such as bleeding and pregnancy; your prescriber's own instructions come first.
Get emergency help for
Call 911 or go to an emergency room for:
- Swelling of the face, lips, tongue or throat
- Trouble breathing or swallowing
- Fainting
Call your prescriber right away about
Do not wait for your next visit for:
- Severe stomach pain that will not go away, with or without vomiting
- Fatigue with dizziness, or signs of dehydration
- A possible pregnancy
- Very heavy or unusual bleeding
- Sweating with shakiness or confusion, especially if you have type 2 diabetes
Bring up at your next visit
Mention hot flashes, cycle changes or ongoing tiredness that are bothering you, even if they are mild. Your log gives your prescriber the dates and details.
Key takeaways
- Fatigue is listed on the Wegovy®, Zepbound® and Foundayo™ labels, reported more often than with placebo in their weight trials; the Ozempic® and Mounjaro® labels list it too.
- Hot flashes, flushing and period changes are not listed as side effects on any of the six labels covered here; log them and mention them anyway.
- Sweating with shakiness, confusion or a fast heartbeat can be a sign of low blood sugar, especially with type 2 diabetes.
- A late period can mean pregnancy: take a test and call your prescriber. Mounjaro®, Zepbound® and Foundayo™ have birth control pill notes.
- Every label carries a boxed warning about thyroid C-cell tumors. Tracking never replaces a call when something is severe or worrying.
Put dates on what you are feeling.
Pep AI logs symptoms with a severity rating next to your doses, sleep and meals, and makes a PDF of your doses and meal totals. Free to try on iPhone and Android.
Frequently asked questions
Keep reading
Sources
- Wegovy® (semaglutide) injection and tablets prescribing information and Medication Guide, Novo Nordisk / FDA (revised 06/2026)
- Zepbound® (tirzepatide) prescribing information and Medication Guide, Eli Lilly / FDA (revised 08/2026)
- Mounjaro® (tirzepatide) prescribing information, Eli Lilly / FDA (revised 08/2026)
- Ozempic® (semaglutide) injection prescribing information and Medication Guide, Novo Nordisk / FDA (revised 05/2026)
- Rybelsus® and Ozempic® tablets (semaglutide) prescribing information, Novo Nordisk / FDA (revised 01/2026)
- Foundayo™ (orforglipron) prescribing information, Eli Lilly / FDA (revised 07/2026)
This guide is general information based on FDA prescribing information and published research. No GLP-1 medication is FDA-approved to treat hot flashes, menstrual changes or menopause symptoms. Pep AI does not recommend any medicine, any dose, or any use that is not on a medicine's label. It is not medical advice and does not replace your prescriber, gynecologist or pharmacist, and Pep AI is not affiliated with Novo Nordisk or Eli Lilly. If a symptom is severe, getting worse, or worrying you, contact your healthcare provider. In an emergency, call 911.
Published by the Pep AI team · Updated November 2026